Smith Law Firm Sues Funders in Talc Cases
Mississippi talc firm representing 11,500 claimants accuses Ellington Financial, ICG, and Stifel of withholding $30M to seize case fees.
The Smith Law Firm, a Mississippi-based plaintiffs firm representing approximately 11,500 people with talc-related cancer claims against Johnson and Johnson, has sued three of its litigation funders in federal court, alleging they engineered a scheme to seize control of the firm’s case inventory.
The amended complaint, filed February 11, 2026, in the US District Court for the Southern District of Mississippi, names Ellington Financial, ICG Investments, and Stifel Financial Corp. as defendants.
What the Complaint Alleges
Smith Law Firm claims the three financial institutions committed to a multi-tranche loan totaling tens of millions of dollars to fund the firm’s talc litigation operations. The arrangement included a second tranche of approximately $30 million.
According to the complaint, the funders withheld access to that second tranche after J&J’s repeated bankruptcy filings delayed case resolutions for years. Without those funds, Smith Law could not meet the required cash interest payments on its existing loan and was placed in default.
The firm’s attorneys at Carner and Rosemon characterized the alleged strategy in the filing: “The Defendants have executed what is commonly referred to as a ‘loan-to-own’ scheme.”
The complaint further alleges that “from the outset the Defendants conspired to defraud SLF knowing that this fraud would most likely result in SLF defaulting on its SLF1 loan interest payments and quarterly talc expenses which would allow the Defendants to pirate the SLF case fees.”
The CLO Allegation
One of the more unusual claims in the complaint involves the structure of the loan itself. Smith Law alleges the funders included the $30 million second tranche solely to inflate the overall loan size so it could be placed into a collateralized loan obligation, a structured financial product that bundles loans and sells them to investors.
If true, this would connect the litigation finance industry to the same Wall Street securitization mechanisms used in other debt markets. The allegation has drawn attention in legal industry coverage.
How J&J’s Bankruptcy Strategy Created the Pressure
The financial squeeze described in the complaint did not happen in a vacuum. Johnson and Johnson filed for bankruptcy three times using a strategy known as the “Texas Two-Step,” in which the company created a subsidiary to absorb its talc liabilities and placed that subsidiary in bankruptcy.
All three attempts were rejected by courts. The most recent rejection came on April 1, 2025, and J&J confirmed it would not appeal. But the years of delay had real consequences for firms carrying litigation funding debt, since interest continued to accrue while cases sat frozen.
Smith Law alleges it felt comfortable buying out its former partner Porter Malouf’s interest in the joint venture, using a loan from ICG, because it believed the $30 million second tranche would be available. When that funding did not materialize, the firm was left financially exposed.
Background on the Firm and the Litigation
R. Allen Smith Jr. founded the Smith Law Firm in Ridgeland, Mississippi, in 2007. He filed the first talcum powder and ovarian cancer case against J&J and tried the first such case to verdict in South Dakota federal court in 2013. The firm has led 10 talc and ovarian cancer cases against J&J, securing verdicts totaling nearly $1 billion, including a landmark $72 million verdict for plaintiff Jackie Fox.
The firm’s talc cases stem from a joint venture formed in 2013 with Beasley Allen and Porter Malouf. Under the original agreement, Beasley Allen handled 50% of the work and expenses, plus all client contact. The venture eventually encompassed more than 11,000 claims.
Smith Law and Beasley Allen are separately embroiled in their own dispute. Beasley Allen has sued Smith and Porter Malouf over the J&J settlement vote, alleging that Smith pushed clients to support a controversial settlement plan because of financial pressure from its funders. Smith has countersued Beasley Allen for defamation.
Litigation Funding Under Scrutiny
Third-party litigation funding has grown into an estimated $15.2 billion industry, with projections reaching $31 billion by 2028. In mass tort cases, funding arrangements regularly exceed $50 million per matter.
The Smith Law Firm complaint adds to growing scrutiny of these arrangements. Since 2021, New Jersey’s federal courts, where the J&J talc multidistrict litigation is based, have required parties to disclose sources of third-party litigation funding, including the funder’s identity and financial interest.
An October 2025 report from the US Chamber of Commerce Institute for Legal Reform found that third-party litigation funding “operates largely in secret,” with funders investing in high-dollar litigation without appearing on court dockets or being subject to meaningful oversight.
None of the three defendants have publicly responded to the complaint.
References
Reuters. Law firm in J&J baby powder cases sues its litigation funders.
https://www.reuters.com/legal/litigation/law-firm-jj-baby-powder-cases-sues-its-litigation-funders-2025-02-18/
Bloomberg Law. Talcum Law Firm Accuses Litigation Funders of 'Pirating' Cases.
https://news.bloomberglaw.com/business-and-practice/talcum-law-firm-accuses-litigation-funders-of-pirating-cases
Law360. Talc MDL Law Firm Accuses Litigation Funders Of Case Piracy.
https://www.law360.com/bankruptcy-authority/articles/2441925/talc-mdl-law-firm-accuses-litigation-funders-of-case-piracy
JD Journal. Law Firm in J&J Baby Powder Cases Sues Litigation Funders.
https://www.jdjournal.com/2026/02/17/law-firm-j-and-j-baby-powder-cases-sue-litigation-funders/
Bloomberg Law. J&J Talc Suit Law Firms Clash Over $6.5 Billion Settlement.
https://news.bloomberglaw.com/business-and-practice/j-j-talc-suit-law-firms-clash-over-6-5-billion-settlement-deal
Reader Q&A
Frequently Asked Questions
What is a 'loan-to-own' scheme in litigation funding?
A “loan-to-own” scheme refers to an alleged strategy where lenders extend credit with the intention of forcing a default, allowing them to acquire the borrower’s assets. In this case, Smith Law Firm alleges its funders withheld a promised $30 million loan tranche to trigger a default and gain control of fees from 11,500 talc cases.
How does this affect people with pending talc claims?
The lawsuit is between Smith Law Firm and its financial backers. It does not directly affect the underlying talc claims against Johnson and Johnson. However, financial disputes involving plaintiffs’ firms can complicate or delay case resolution.
Why did the litigation funders allegedly withhold the loan?
According to the complaint, the funders withheld a $30 million second tranche of funding after J&J’s bankruptcy filings delayed case resolutions. Smith Law alleges this was intentional, designed to put the firm in default so the funders could take over the firm’s litigation fees.
How many talc lawsuits are pending against Johnson and Johnson?
More than 67,000 talc lawsuits remain pending as of early 2026, consolidated in multidistrict litigation in New Jersey federal court. Smith Law Firm’s 11,500 cases represent a significant portion of the overall docket.
How much will I get from Johnson and Johnson settlement?
No global Johnson & Johnson talcum powder settlement exists as of May 2026, with the latest $9 billion proposal rejected by a Texas bankruptcy judge in April 2025. Individual talcum powder lawsuit payouts for people with mesothelioma linked to asbestos-contaminated talc have ranged from $1 million to $1.4 million on average, based on legal industry estimates and verdicts like a $45 million award (including $32.6 million compensatory) in Illinois. Factors such as injury severity, medical costs, lost wages, and case details influence amounts, with some verdicts reduced on appeal, such as a California case dropping from $966 million to $16 million in March 2026. Overall talc lawsuit settlements average around $500,000 per plaintiff across ovarian cancer and mesothelioma claims. Settlement terms are often confidential, and companies settle without admitting liability.
Has anyone received a settlement from Johnson & Johnson?
Yes, people with mesothelioma and ovarian cancer have received settlements from Johnson & Johnson for claims involving asbestos-contaminated talc products. Notable examples include a $700 million multistate settlement in 2024 for deceptive marketing practices and a $100 million settlement in 2020 resolving over 1,000 claims. Verdicts with settlements have ranged from $45 million in an Illinois mesothelioma case to $966 million in a California case, though global settlement proposals like J&J’s $9 billion offer were rejected as of 2025. Ongoing lawsuits number around 67,000 in New Jersey.
Is it too late to sue Johnson and Johnson?
No, it is not too late to sue Johnson & Johnson for talcum powder claims as of May 2026. The multidistrict litigation (MDL) includes 67,623 pending claims, with new lawsuits still being added monthly. Statutes of limitations vary by state, typically 1-6 years from cancer diagnosis or a loved one’s death, so people with mesothelioma or ovarian cancer from alleged asbestos in talc products may still qualify depending on their timeline. Three J&J subsidiary bankruptcy attempts to resolve claims have been rejected, keeping cases active. Trial lawyers continue filing suits amid ongoing mediation.
Does Johnson and Johnson powder have asbestos in it?
Johnson & Johnson talc-based baby powder has tested positive for asbestos contamination in some samples from the 1970s to early 2000s, according to internal documents and lab reports cited by Reuters and court records. Talc deposits often occur near asbestos, allowing fibers to mix during mining and persist in fine powders that can be inhaled. The company discontinued talc-based powder in North America by 2020 and globally by 2023, switching to cornstarch, while maintaining its products were asbestos-free based on its own tests. Juries have ruled against the company in related lawsuits linking exposure to mesothelioma and other diseases.